Your current location:HomeMedia CenterEnterprise News
The Company Signed a Contract With CuraMedical B.V.,
Time:
2014-04-02
The Company Signed a Contract With CuraMedical B.V.,

In 2014, the company cooperated with the famous Dutch enterprise CuraMedical B.V. and the Curacel  series of global  leading-edge hemostatic products have been successfully introduced into China.


On July 1, 2014, both parties signed the agreement of authorizing the company as exclusive agent of China for oxidized regenerated cellulose hemostat .Company Chairman Shen Hao, General Manager Hu Jinyuan, CuraMedical B.V. CEO Fred J. Hoogland  attended the signing ceremony in Guangzhou.




Related To Recommend

The company Moved the Headquarters
On March 31, 2022, with the invitation of The People's Government of Huangpu District, Guangzhou, Sunvale Medical moved ...
 Developing Products In Clinical Trials
On January 20, 2022, one neurosurgical product under development entered the clinical trial which will run from January ...
 Developing Products  In Clinical Trials
On January 20, 2022, two neurosurgical products under development entered  clinical trial  which will run from January 2...
The company's Developing Products In Clinical Trials
In November 2021, one neurosurgical product under development entered the stage of clinical trial . The trial will run f...